Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Breast cancer is one of the leading causes of increasing deaths in women worldwide. The complex nature (microcalcification and masses) of breast cancer cells makes it quite difficult for radiologists to diagnose it properly. Subsequently, various computer-aided diagnosis (CAD) systems have previously been developed and are being used to aid radiologists in the diagnosis of cancer cells. However, due to intrinsic risks associated with the delayed and/or incorrect diagnosis, it is indispensable to improve the developed diagnostic systems. In this regard, machine learning has recently been playing a potential role in the early and precise detection of breast cancer. This paper presents a new machine learning-based framework that utilizes the Random Forest, Gradient Boosting, Support Vector Machine, Artificial Neural Network, and Multilayer Perception approaches to efficiently predict breast cancer from the patient data. For this purpose, the Wisconsin Diagnostic Breast Cancer (WDBC) dataset has been utilized and classified using a hybrid Multilayer Perceptron Model (MLP) and 5-fold cross-validation framework as a working prototype. For the improved classification, a connection-based feature selection technique has been used that also eliminates the recursive features. The proposed framework has been validated on two separate datasets, i.e., the Wisconsin Prognostic dataset (WPBC) and Wisconsin Original Breast Cancer (WOBC) datasets. The results demonstrate improved accuracy of 99.12% due to efficient data preprocessing and feature selection applied to the input data.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398810PMC
http://dx.doi.org/10.1155/2022/5869529DOI Listing

Publication Analysis

Top Keywords

breast cancer
28
cancer
8
machine learning
8
cancer cells
8
feature selection
8
breast
6
predicting breast
4
cancer leveraging
4
leveraging supervised
4
machine
4

Similar Publications

Chemotherapeutic resistance is a significant issue in the treatment of breast cancer, which is related to pyroptosis inhibition. Increasing evidence suggests that long non-coding RNAs (lncRNAs) contribute to tumorigenesis and drug resistance. In this study we investigated the role of the lncRNA STMN1P2 in doxorubicin resistance in breast cancer, as well as its correlation with pyroptosis inhibition.

View Article and Find Full Text PDF

Comprehensive genomic profiling (CGP) expands treatment options for solid tumor patients and identifies hereditary cancers. However, in Japan, confirmatory tests have been conducted in only 31.6% of patients with presumed germline pathogenic variants (GPVs) detected through tumor-only testing.

View Article and Find Full Text PDF

Purpose: Recent advancements in medical technologies have made trans-arterial treatment of breast cancer feasible. Consequently, understanding the vascular anatomies of breast cancers and axillary lymph node metastases has become indispensable for sophisticated treatments. The aim of this study was to determine the vascular anatomy of the breast, which is crucial for trans-arterial chemoembolization in patients with breast cancer.

View Article and Find Full Text PDF